{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:53:00Z","timestamp":1780080780494,"version":"3.54.0"},"reference-count":44,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Intra-abdominal candidiasis (IAC) is associated with significant diagnostic and therapeutic challenges in critically ill patients. Traditional fungal cultures are slow, delaying appropriate antifungal treatment. (1,3)-\u03b2-D-glucan (BDG), a component of the fungal cell wall, has emerged as a potential biomarker for IAC, but its use in ICU settings is complicated by frequent false-positives results from invasive procedures and underlying conditions. This review examines the diagnostic value of BDG when present in serum and peritoneal fluid. While serum BDG is effective for excluding invasive fungal infections like candidemia, its specificity for IAC remains low in critically ill patients. Recent studies suggest that BDG levels in peritoneal fluid may provide better diagnostic accuracy, distinguishing IAC from bacterial peritonitis with higher specificity. We discuss the advantages, limitations, and practical aspects of BDG testing, emphasizing the potential of peritoneal BDG as a complementary tool. Further research is needed to refine diagnostic thresholds, validate its clinical utility, and establish the role of peritoneal BDG in improving timely, targeted antifungal treatment for IAC.<\/jats:p>","DOI":"10.3390\/jof11020091","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:24:31Z","timestamp":1737696271000},"page":"91","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reevaluating the Value of (1,3)-\u03b2-D-Glucan for the Diagnosis of Intra-Abdominal Candidiasis in Critically Ill Patients: Current Evidence and Future Directions"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4099-8106","authenticated-orcid":false,"given":"Emmanuel","family":"Novy","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Perioperative Medicine, Surgical Intensive Care Unit, CHRU-Nancy, F-54000 Nancy, France"},{"name":"Universit\u00e9 de Lorraine, SIMPA, F-54000 Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8427-0347","authenticated-orcid":false,"given":"Mathieu","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Perioperative Medicine, Surgical Intensive Care Unit, CHRU-Nancy, F-54000 Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1240-856X","authenticated-orcid":false,"given":"Anne","family":"Debourgogne","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Lorraine, SIMPA, F-54000 Nancy, France"},{"name":"Mycology and Parasitology Laboratory, CHRU-Nancy, F-54000 Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6055-0034","authenticated-orcid":false,"given":"Claire","family":"Roger","sequence":"additional","affiliation":[{"name":"UR-UM103 IMAGINE, Univ Montpellier, Division of Anesthesia and Critical Care, Pain and Emergency Medicine, N\u00eemes University Hospital, F-30029 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","article-title":"Incidence and Outcome of Invasive Candidiasis in Intensive Care Units (ICUs) in Europe: Results of the EUCANDICU Project","volume":"23","author":"Bassetti","year":"2019","journal-title":"Crit. Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00134-020-06240-x","article-title":"Invasive Candidiasis in Critical Care: Challenges and Future Directions","volume":"46","author":"Logan","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 Consensus Definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00134-023-07034-7","article-title":"Antifungal Stewardship in Critically Ill Patients","volume":"49","author":"Nseir","year":"2023","journal-title":"Intensive Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jac\/dkad139","article-title":"Invasive Candidiasis: Current Clinical Challenges and Unmet Needs in Adult Populations","volume":"78","author":"Soriano","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s13054-023-04761-7","article-title":"Combination of Serum and Peritoneal 1.3-Beta-D-Glucan Can Rule out Intra-Abdominal Candidiasis in Surgical Critically Ill Patients: A Multicenter Prospective Study","volume":"27","author":"Novy","year":"2023","journal-title":"Crit. Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CLEP.S459600","article-title":"Epidemiology of Invasive Candidiasis","volume":"16","author":"Bays","year":"2024","journal-title":"Clin. Epidemiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s15010-009-8249-6","article-title":"The Epidemiology of Intra-Abdominal Flora in Critically Ill Patients with Secondary and Tertiary Abdominal Sepsis","volume":"37","author":"Weel","year":"2009","journal-title":"Infection"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"87.e1","DOI":"10.1016\/j.cmi.2014.08.011","article-title":"Invasive Candida Infections in Surgical Patients in Intensive Care Units: A Prospective, Multicentre Survey Initiated by the European Confederation of Medical Mycology (ECMM) (2006\u20132008)","volume":"21","author":"Klingspor","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00134-015-3866-2","article-title":"A Multicenter Multinational Study of Abdominal Candidiasis: Epidemiology, Outcomes and Predictors of Mortality","volume":"41","author":"Bassetti","year":"2015","journal-title":"Intensive Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Vergidis, P., Clancy, C.J., Shields, R.K., Park, S.Y., Wildfeuer, B.N., Simmons, R.L., and Nguyen, M.H. (2016). Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153247"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13613-015-0103-7","article-title":"Systemic Antifungal Therapy for Proven or Suspected Invasive Candidiasis: The AmarCAND 2 Study","volume":"6","author":"Leroy","year":"2016","journal-title":"Ann. Intensive Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijid.2016.11.403","article-title":"Secondarily Documented Invasive Candidiasis Is Unpredictable Using Traditional Risk Factors in Non Transplant\u2014Non-Neutropenic Adult ICU Patients","volume":"54","author":"Bailly","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","article-title":"Resistance of Candida to Azoles and Echinocandins Worldwide","volume":"25","author":"Pristov","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00134-013-3109-3","article-title":"A Research Agenda on the Management of Intra-Abdominal Candidiasis: Results from a Consensus of Multinational Experts","volume":"39","author":"Bassetti","year":"2013","journal-title":"Intensive Care Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Alves, J., Alonso-Tarr\u00e9s, C., and Rello, J. (2022). How to Identify Invasive Candidemia in ICU\u2014A Narrative Review. Antibiotics, 11.","DOI":"10.3390\/antibiotics11121804"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e01909-17","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing Invasive Candidiasis","volume":"56","author":"Clancy","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00068-019-01161-x","article-title":"Usefulness of Gram Stain Examination of Peritoneal Fluid in Postoperative Peritonitis to Guide Empirical Antibiotherapy","volume":"46","author":"Augustin","year":"2020","journal-title":"Eur. J. Trauma Emerg. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/myc.13101","article-title":"Cell Wall Polysaccharides from Pathogenic Fungi for Diagnosis of Fungal Infectious Disease","volume":"63","author":"Lei","year":"2020","journal-title":"Mycoses"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cort\u00e9s, J.C.G., Curto, M.-\u00c1., Carvalho, V.S.D., P\u00e9rez, P., and Ribas, J.C. (2019). The Fungal Cell Wall as a Target for the Development of New Antifungal Therapies. Biotechnol. Adv., 37.","DOI":"10.1016\/j.biotechadv.2019.02.008"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jb\/mvq026","article-title":"Sadaaki Iwanaga: Discovery of the Lipopolysaccharide- and \u03b2-1,3-D-Glucan-Mediated Proteolytic Cascade and Unique Proteins in Invertebrate Immunity","volume":"147","author":"Kawabata","year":"2010","journal-title":"J. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1309\/LM8BW8QNV7NZBROG","article-title":"(1\u20133)-\u03b2-D-Glucan Assay: A Review of Its Laboratory and Clinical Application","volume":"42","author":"Wright","year":"2011","journal-title":"Lab. Med."},{"key":"ref_24","first-page":"1368","article-title":"Impact of 3-D Glucan during Liver Transplantation","volume":"61","author":"Sanada","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1519.e1","DOI":"10.1016\/j.cmi.2021.05.031","article-title":"Comparison of \u03b2-D-Glucan Levels between Candida auris and Other Candida Species at the Time of Candidaemia: A Retrospective Study","volume":"27","author":"Farooqi","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* Guideline for the Diagnosis and Management of Candida Diseases 2012: Non-Neutropenic Adult Patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s00134-016-4307-6","article-title":"Therapeutic Management of Peritonitis: A Comprehensive Guide for Intensivists","volume":"42","author":"Montravers","year":"2016","journal-title":"Intensive Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Finkelman, M.A. (2020). Specificity Influences in (1\u21923)-\u03b2-d-Glucan-Supported Diagnosis of Invasive Fungal Disease. J. Fungi, 7.","DOI":"10.3390\/jof7010014"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"ofy296","DOI":"10.1093\/ofid\/ofy296","article-title":"Serum 1,3-Beta-D-Glucan Values During and After Laparoscopic and Open Intestinal Surgery","volume":"5","author":"Szyszkowitz","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2255680","DOI":"10.1080\/0886022X.2023.2255680","article-title":"The Influence of Continuous Renal Replacement Therapy on 1,3-\u03b2-d-Glucan Levels in Critically Ill Patients: A Single-Center Retrospective Propensity Score Study","volume":"45","author":"Cabanilla","year":"2023","journal-title":"Ren. Fail."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Dupont, H., Malaquin, S., Villeret, L., Macq, P.-Y., Ammenouche, N., Tinturier, F., Diouf, M., Rumbach, M., and Chouaki, T. (2022). Is SS-d-Glucan Relevant for the Diagnosis and Follow-Up of Intensive Care Patients with Yeast-Complicated Intra-Abdominal Infection?. J. Fungi, 8.","DOI":"10.3390\/jof8050487"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00134-022-06733-x","article-title":"(1\u2009\u2192\u20093)-\u03b2-D-Glucan-Guided Antifungal Therapy in Adults with Sepsis: The CandiSep Randomized Clinical Trial","volume":"48","author":"Bloos","year":"2022","journal-title":"Intensive Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00134-022-06766-2","article-title":"Is (1,3)-\u03b2-D-Glucan Useless to Guide Antifungal Therapy in ICU?","volume":"48","author":"Estella","year":"2022","journal-title":"Intensive Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00134-017-4932-8","article-title":"Biomarker-Based Strategy for Early Discontinuation of Empirical Antifungal Treatment in Critically Ill Patients: A Randomized Controlled Trial","volume":"43","author":"Loridant","year":"2017","journal-title":"Intensive Care Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13054-020-03265-y","article-title":"(1,3)-\u03b2-D-Glucan-Based Empirical Antifungal Interruption in Suspected Invasive Candidiasis: A Randomized Trial","volume":"24","author":"Posteraro","year":"2020","journal-title":"Crit. Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e0072523","DOI":"10.1128\/aac.00725-23","article-title":"\u03b2-(1\u21923)-D-Glucan- and Mannan-Guided Early Termination of Antifungal Therapy in ICU Patients: A Randomized Controlled Study","volume":"67","author":"Erb","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.23736\/S0375-9393.18.12619-8","article-title":"Determination of 1,3-\u03b2-D-Glucan in the Peritoneal Fluid for the Diagnosis of Intra-Abdominal Candidiasis in Critically Ill Patients: A Pilot Study","volume":"84","author":"Novy","year":"2018","journal-title":"Minerva Anestesiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"myad029","DOI":"10.1093\/mmy\/myad029","article-title":"Use of 1,3-Beta-d-Glucan Concentration in Peritoneal Fluid for the Diagnosis of Intra-Abdominal Candidiasis in Critically Ill Patients","volume":"61","author":"Nourry","year":"2023","journal-title":"Med. Mycol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/microbiolres12010015","article-title":"Protocol for the pBDG2 Study: Prospective Evaluation of 1.3-\u03b2-D-Glucan in the Peritoneal Fluid for the Diagnosis of Intra-Abdominal Candidiasis in Critically Ill Patients","volume":"12","author":"Novy","year":"2021","journal-title":"Microbiol. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","article-title":"ESICM\/ESCMID Task Force on Practical Management of Invasive Candidiasis in Critically Ill Patients","volume":"45","author":"Antonelli","year":"2019","journal-title":"Intensive Care Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"954.e9","DOI":"10.1016\/j.cmi.2015.06.002","article-title":"Initial Serum (1,3)-\u03b2-D-Glucan as a Predictor of Mortality in Proven Candidaemia: Findings from a Retrospective Study in Two Teaching Hospitals in Italy and Brazil","volume":"21","author":"Giacobbe","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13054-024-05022-x","article-title":"Prognostic Value of Serial (1,3)-\u03b2-D-Glucan Measurements in ICU Patients with Invasive Candidiasis","volume":"28","author":"Carelli","year":"2024","journal-title":"Crit. Care"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s15010-023-02084-x","article-title":"Laboratory and Clinical Management Capacity for Invasive Fungal Infections: The Italian Landscape","volume":"52","author":"Vena","year":"2024","journal-title":"Infection"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11046-024-00830-9","article-title":"Multicentric Study on the Clinical Mycology Capacity and Access to Antifungal Treatment in Portugal","volume":"189","author":"Fernandes","year":"2024","journal-title":"Mycopathologia"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/2\/91\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:35:19Z","timestamp":1759919719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/2\/91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jof11020091"],"URL":"https:\/\/doi.org\/10.3390\/jof11020091","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}